MedPath

The Effects of Synbiotics on Morbidity and Mortality in Preterm Infants

Not Applicable
Conditions
Necrotizing Enterocolitis
Sepsis
Registration Number
NCT01807858
Lead Sponsor
Dr. Sami Ulus Children's Hospital
Brief Summary

Study, the inclusion of very low birth weight premature infants followed in Dr.Sami Ulus Maternity and Children Training and Research Hospital, Department of Neonatology; be randomized to very low birth weight premature infants began eating until you are discharged from the hospital once a day to feed a group+ 900 mg of 5 billion active Bifidobacterium lactis, the addition of chicory inulin, in the other group given placebo; Patients taking weekly blood cultures, the presence of residues in both groups during feeding, to evaluate the incidence of NEC and sepsis are planned. Randomization and the number of patients planned to separate into groups.

Detailed Description

Patients separated into four groups using the sealed envelope method.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
400
Inclusion Criteria
  • VLBW infants admitted to NICU at the first 7 days of life
Exclusion Criteria
  • expected life lower than 7 days,
  • babies who could not be fed (any metabolic disorders, gastrointestinal system surgical disorders etc.),
  • severe asphyxia,
  • severe congenital anomaly

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Necrotizing enterocolitis8 weeks

Developing of \>= grade 2 necrotizing enterocolitis suggested by radiological investigation

Secondary Outcome Measures
NameTimeMethod
length of hospital stay16 weeks

length of hospital stay

Trial Locations

Locations (4)

Şevket Yılmaz Research Hospital

🇹🇷

Bursa, Turkey

Diyarbakır Research Hospital

🇹🇷

Diyarbakır, Turkey

Okmeydani Research Hospital

🇹🇷

İstanbul, Turkey

Umraniye Research Hospital

🇹🇷

İstanbul, Turkey

Şevket Yılmaz Research Hospital
🇹🇷Bursa, Turkey
Arzu Akdağ, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.